Recent studies indicate that nephron progenitor cells of the embryonic kidney are arranged in a series of compartments of an increasing state of differentiation. The earliest progenitor compartment, distinguished by expression of CITED1, possesses greater capacity for renewal and differentiation than later compartments. Signaling events governing progression of nephron progenitor cells through stages of increasing differentiation are poorly understood, and their elucidation will provide key insights into normal and dysregulated nephrogenesis, as well as into regenerative processes that follow kidney injury. In this study, we found that the mouse CITED1 + progenitor compartment is maintained in response to receptor tyrosine kinase (RTK) ligands that activate both FGF and EGF receptors. This RTK signaling function is dependent on RAS and PI3K signaling but not ERK. In vivo, RAS inactivation by expression of sprouty 1 (Spry1) in CITED1 + nephron progenitors results in loss of characteristic molecular marker expression and in increased death of progenitor cells. Lineage tracing shows that surviving Spry1-expressing progenitor cells are impaired in their subsequent epithelial differentiation, infrequently contributing to epithelial structures. These findings demonstrate that the survival and developmental potential of cells in the earliest embryonic nephron progenitor cell compartment are dependent on FGF/EGF signaling through RAS.
INTRODUCTION
Nephrogenesis serves as an important model system for the study of mesenchymal-epithelial interactions in development. Both organ culture and gene inactivation studies have provided a detailed understanding of many interactions between the nephrogenic mesenchyme and ureteric bud that underlie the development of the fully formed organ (Grobstein, 1953; Grobstein and Dalton, 1957; Vainio and Lin, 2002) . These investigations have recently been complemented with highresolution mapping of gene expression and demonstrate that the population of nephron progenitor cells capping the ureteric bud (the 'cap mesenchyme') can be divided into a series of subcompartments based on the expression of distinct transcriptional regulators (Boyle et al., 2008; Brunskill et al., 2008; Kobayashi et al., 2008; Mugford et al., 2009) . Expression of the transcriptional co-factor CITED1 characterizes early nephron progenitors, whereas loss of CITED1 and gain of the LEF1 transcription factor define the pretubular aggregate compartment that precedes epithelialization of the nascent nephron during differentiation. The functional significance of division of the cap mesenchyme into discrete progenitor cell compartments is at present not fully understood. One possibility is that early CITED1 + progenitors are resistant to the inductive activities of Wnt signaling because they do not express the Wnt transcription factor LEF1. Insulation from inductive signals would ensure the maintenance of a progenitor cell pool for continued rounds of nephron differentiation. Compartmentalization, which is a feature of numerous progenitor cell niches in the adult, prevents premature exhaustion of the highest order progenitors, and it is an intriguing possibility that progenitor cell organization in the developing kidney might fit this paradigm (Greco and Guo, 2010) .
Previous investigations identified a number of genes required for nephron progenitor cell maintenance. Within nephrogenic mesenchyme, expression of the Wt1 transcription factor is essential for mesenchyme survival, whereas Six2 is crucial for self-renewal and is required to suppress the premature differentiation of nephron progenitor cells (Kobayashi et al., 2008; Kreidberg et al., 1993; Self et al., 2006) . Eya1, which lies upstream of Six2, is necessary for induction of the mesenchyme (Kiefer et al., 2010; Nishinakamura et al., 2001; Xu et al., 1999) . Genetic inactivation of Bmp7, which is expressed both in cap mesenchyme and ureteric bud tissue, results in reduced proliferation and premature depletion of nephron progenitor cells (Blank et al., 2009; Dudley et al., 1995; Luo et al., 1995) . Inactivation of FGF receptors 1 and 2 in nephrogenic mesenchyme completely abrogates its growth, suggesting an essential role for FGF signaling (Poladia et al., 2006) . FGF2 is secreted from the ureteric bud and recombinant FGF2 maintains nephrogenic mesenchyme in culture, making it an attractive candidate signal for progenitor cell maintenance in vivo (Plisov et al., 2001) . However, the lack of a kidney development phenotype in the Fgf2 null mouse argues that a group of redundant ligands might be responsible for progenitor maintenance (Dono et al., 1998; Ortega et al., 1998) .
Although genetic and biochemical studies have revealed essential functions for specific genes and pathways in maintenance of the cap mesenchyme as a whole, we have yet to define the pathways required for the maintenance of specific progenitor subcompartments. In this study, we utilize a recently established system for the culture of primary cells derived from the mouse embryonic kidney to screen for growth factors that promote maintenance of the early CITED1 + nephron progenitor cell compartment. We find that a specific group of FGF and EGF ligands supports CITED1 + progenitor maintenance by means of the intracellular signaling mediator RAS (HRAS1 -Mouse Genome Informatics). We test this hypothesis in vivo by driving overexpression of sprouty 1 (Spry1), an inhibitor of the receptor tyrosine kinases (RTKs) that activate RAS, specifically in the CITED1 + progenitor compartment. We find that progenitor cell survival is impaired and that there is a reduced contribution of Spry1-expressing progenitors to the development of epithelial structures.
MATERIALS AND METHODS

Cell culture
Nephrogenic zone cells (NZCs) were extracted from E17.5 mouse kidneys and cultured as previously described (Blank et al., 2009) . Growth factors used are listed in Table 1 . The FGF inhibitor PD173074 (50 nM, Sigma), RAS inhibitor FPT III (25 M, EMD Biosciences), PI3K inhibitor LY294002 (50 M, Cell Signaling Technology) and ERK activation inhibitor peptide I (2.5 M, EMD Biosciences) and Wnt inhibitor IWR1 (10 M, Tocris Bioscience) were used at concentrations verified by the respective vendors to be specific for the kinases under study, with limited off-target effects.
Immunofluorescence, X-gal staining and microscopy
Monolayer cells were fixed and stained as previously described (Blank et al., 2009) . Antibodies used were: CITED1, 1:100 (NeoMarkers); SIX2, 1:50 (Santa Cruz Biotechnology); LEF1, 1:50 (Cell Signaling Technology); PAX2, 1:100 (Invitrogen); pHH3, 1:100 (Cell Signaling Technology); GFP, 1:100 (Abcam); and WT1, 1:100 (Santa Cruz Biotechnology). Paraffin sections were immunostained as previously described (Blank et al., 2009 ). Immunofluorescence was quantified by measuring the integrated density using ImageJ. Values were normalized to the number of DAPI-stained nuclei in each field. X-gal staining was performed as described (Dudley et al., 1995) .
Quantitative (q) PCR
RNA was extracted from NZCs plated in monolayer derived from pools of E17.5 mouse embryonic kidneys using the RNeasy Micro Kit (Qiagen). cDNA synthesis was performed using qScript cDNA SuperMix (Quanta Biosciences). qPCR was carried out using iQ SYBR Green Supermix (BioRad). Each assay was performed in triplicate and fold changes were calculated using the DDCT method, normalized to endogenous Actb levels and displayed relative to the controls. Specificities of primer sets were determined by melt curve analysis on qPCR-generated amplicons. Average values (± s.d.) of three technical replicates from NZCs of 20-24 pooled embryonic kidneys are shown in the figures.
Statistics
P-values for protein quantitation of immunofluorescent images and TUNEL staining were derived using a two-tailed homoscedastic Student's t-test. For qPCR, owing to the differing variance of data points as the cycle threshold increases, P-values shown were calculated using a two-tailed heteroscedastic Student's t-test. P<0.05 was considered significant. The standard deviation was calculated for technical replicates derived from NZCs of 20-24 pooled kidneys or the standard error was calculated for true biological replicates derived from independent mice.
Adenoviral vectors and transduction
Transduction with adenovirus was carried out as previously described (Blank et al., 2009 ) for 24 hours with a multiplicity of infection of 500 in fibronectin-coated wells using serum-free medium.
Mouse strains and tamoxifen injection
Animal care was in accordance with the National Research Council Guide for the Care and Use of Laboratory Animals and protocols were approved by the Institutional Animal Care and Use Committee of Maine Medical Center. NZCs were derived from kidneys of E17.5 ICR mice. Cited1-CreER T2 mice, R26R lacZ mice and Spry1-overexpressing transgenic mice are maintained on an FVB/NJ background (Soriano, 1999; Boyle et al., 2008; Yang et al., 2008) . Pregnant mice were injected at the times indicated with 6 mg tamoxifen in corn oil per 40 g mouse.
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Development 138 (23) Biglycan (BGN) 2-8 g/ml 2 g/ml BMP4 10-30 ng/ml 50 ng/ml BMP7 100-600 ng/ml 50 ng/ml DKK1 0.8-4 g/ml 1 g/ml EGF 0.1-0.4 ng/ml 100 ng/ml FGF1 0.1-200 ng/ml 25-100 ng/ml FGF2 0.5-2.5 ng/ml 25-100 ng/ml FGF7 10-50 ng/ml 25-100 ng/ml FGF8b 1-3 ng/ml 25-100 ng/ml FGF9 1-5 ng/ml 25-100 ng/ml FGF10 20-100 ng/ml 25-100 ng/ml FGF12 1.6-100 ng/ml 25-100 ng/ml FGF20 0.2-1 ng/ml 25-100 ng/ml GDF11 2-8 ng/ml 100 ng/ml GDNF 5-10 ng/ml 50 ng/ml IL6 0.2-0.8 ng/ml 20 ng/ml Inhibin, beta A (INHBA) 0.5-2 ng/ml 40 ng/ml Insulin (INS) 0.001-20 g/ml 10 g/ml LIF 5 ng/ml 20 ng/ml MDK 0.1-10 ng/ml 7 nM (98.3 ng/ml) NOG 0.006-0.3 g/ml 1 g/ml PDGF-BB 1.5-6 ng/ml 100 ng/ml PLGF 0.1-5 ng/ml 20 ng/ml All-trans retinoic acid (RA) -200 nM SCF 2.5-5 ng/ml 500 ng/ml TGF 0.2 ng/ml 100 ng/ml TGF1 0.04-0.2 ng/ml 50 ng/ml TGF2 0. A primary screen for effects on proliferation was conducted by measuring phospho-histone H3 (pHH3)-positive nuclei in cultured NZCs. Compared with untreated controls, FGF2 was the most potent proliferative factor after 24 hours, increasing proliferation by over 300%, followed by TGF, BMP7 and EGF (Fig. 1A) . Morphologically, cultures treated with FGF2 showed increased spreading, cellularity and attachment of NZCs to the well surface at 24 hours (Fig. 1A, inset) .
Nephron progenitor cells are arranged into distinct compartments within cap mesenchyme, with expression of the transcriptional coactivator CITED1 identifying the earliest nephron progenitor cells and the -catenin-interacting transcription factor LEF1 marking the more differentiated pretubular aggregate cells (Fig.  1B) Mugford et al., 2009 ). Analysis of CITED1 protein expression in growth factor-treated NZC cultures 5101 RESEARCH ARTICLE RTK signaling in nephron progenitors revealed that the proliferative effects of FGF2, TGF and EGF, which are known ligands of the RTK signaling family, correlated with increased numbers of these early progenitors; this was in contrast to the proliferative effects associated with the RTKindependent ligand BMP7 ( Fig. 1C,D ; supplementary material Fig.  S1 ). To ensure that CITED1 + cells promoted by FGF2 treatment retained the capacity to differentiate to the LEF1-expressing pretubular aggregate, we subjected FGF2-treated cultures to treatment with the canonical Wnt signaling activator BIO 18 hours after FGF2 addition. BIO-treated cultures showed a significant increase in LEF1 expression, indicating that they indeed retain the potential to differentiate (supplementary material Fig. S2 ).
The combination of TGF2, LIF, FGF2 and TGF has a strong regulatory effect on nephron progenitor cells in the rat (Plisov et al., 2001 ), and we therefore tested whether these factors might regulate CITED1. We find no evidence of a synergistic effect (data not shown), possibly owing to species differences in response to these factors. Other ligands from our panel known to activate RTK signaling during kidney development, including FGF8, IL6, PLGF (PGF -Mouse Genome Informatics), PDGF, VEGFA and INS (insulin, data not shown), showed no significant increase in CITED1 protein expression (supplementary material Fig. S1 ). Thus, in the mouse, CITED1 expression might be controlled by a specific group of RTK ligands that activate FGF/EGF receptors.
Having ascertained that FGF2, TGF and EGF promote proliferation of NZCs and the expansion of a CITED1
+ early nephron progenitor cell population, we analyzed a more extensive panel of molecular markers characteristic of distinct compartments within the nephrogenic zone. Expression of compartment-specific signature genes in FGF2-treated cultures was assayed, as this growth factor showed the greatest effect of the three on CITED1 protein expression (Fig. 1C,D) . As anticipated, Cited1 showed the greatest increase in expression versus the medium control at 24 hours, indicating expansion or maintenance of the earliest progenitor compartment (Fig. 1E) . Meox1, which marks a newly identified subpopulation within the Cited1 compartment, was highly elevated, as were the more generalized cap mesenchyme markers Six2, Eya1, Sall1 and Pea3 (Etv4 -Mouse Genome Informatics), which are also known to be expressed within the CITED1 + progenitor compartment in vivo (Mugford et al., 2009) . Based on analysis of this functionally essential gene set, we conclude that FGF signaling promotes the early nephron progenitor cell state in NZC cultures.
Immunofluorescent staining clearly showed that increased CITED1 and SIX2 protein expression correlated with the transcriptional activation caused by FGF2 (Fig. 1D,E) . Previous results from our laboratory have revealed that although the NZC culture is composed of greater than 50% PAX2 + nephron progenitors derived from the cap mesenchyme, nearly 40% of the cells in these cultures represent cortical interstitium. To verify that CITED1 expression is increased in PAX2 + nephron progenitors, but not in cortical interstitial cells, following FGF2 treatment, NZCs derived from the Cited1-CreER T2 transgenic strain, which expresses GFP under the control of Cited1, were fixed and costained with anti-PAX2 (green) and anti-GFP (red) antibodies. FGF2 treatment resulted in robust GFP expression only in cells that express PAX2, whereas the majority of PAX2 + progenitors lack GFP expression when cultured in medium alone. CITED1 expression in response to FGF2 thus occurs in nephron progenitor cells derived from the cap mesenchyme rather than the cortical interstitium (Fig. 1F ).
To understand whether FGF2 treatment increases the abundance of early nephron progenitor cells in NZC cultures, or prevents their decline from the time of harvest, we compared Cited1 expression in FGF2-treated and control NZCs over time and normalized the results to those from freshly isolated cells. In medium alone, NZCs progressively lose Cited1 expression over the course of 48 hours, whereas FGF2 treatment causes persistence of Cited1 expression throughout the time course at a level similar to that seen in freshly isolated NZCs (Fig. 1G ). Taken together, these results suggest that FGF acts on nephron progenitors to promote a highly proliferative state and a transcriptional profile that is consistent with the earliest progenitor compartment.
Select FGFs that display cap mesenchyme-specific expression maintain early nephron progenitor cells
Results presented thus far suggest that FGF2 or an FGF2-like protein regulates the renewal program of the primitive CITED1 + progenitor compartment within the cap mesenchyme in vivo. To identify potential FGF candidate genes we reviewed the transcriptome data provided in the GenitoUrinary Molecular Anatomy Project (GUDMAP) database (http://www.gudmap.org). FGF genes expressed within specific subcompartments of the nephrogenic zone include Fgf1, 7, 8, 9, 10, 12 and 20 (Fig. 2) . Multiple candidates are strongly expressed in the cap mesenchyme and several, including Fgf1, 7, 9, 10 and 20, show decreasing expression associated with the cessation of nephrogenesis at postnatal day 3, coincident with the loss of primitive cap markers such as Cited1, Six2, Meox1 and Dpf3 (Mugford et al., 2009) .
To determine which of the FGFs expressed in the nephrogenic zone maintain the early nephron progenitor compartment, NZCs were stimulated with the corresponding recombinant FGFs and maintenance of CITED1 protein expression was measured at 24 hours (Fig. 3A) . Ligand concentrations well exceeded the effective dose (ED 50 ) range as determined in proliferation assays for each individual lot of recombinant FGF (Table 1) . FGF1, 9 and 20 maintained CITED1 protein expression similarly to FGF2, and induced transcription of the primitive cap markers Cited1, Pea3, Meox1 and Six2, whereas FGF7, 8, 10 and 12 showed minimal or no effect (Fig. 3A,B) . Interestingly, the three FGFs capable of substituting for FGF2 in promoting progenitor cell identity are strongly expressed in the cap mesenchyme (Fig. 2) . FGF8, also expressed in the later cap mesenchyme and renal vesicle, showed only a modest effect on early cap marker transcription, even though the specific activity was comparable to, or greater than, that calculated for FGF1, 2, 9 and 20 (Table 1 ). The maintenance of early progenitors could however be achieved by treatment with extremely high concentrations of FGF8 (1600 and 3200 ng/ml; supplementary material Fig. S3A ).
FGFs can be functionally grouped according to the receptors that they activate (Eswarakumar et al., 2005) . Through alternate splicing, two isoforms of FGF receptors 1 and 2 (the b and c isoforms) are generated. These isoforms are predominantly expressed in either epithelial (b) or mesenchymal (c) tissues and display distinct ligand-binding specificities. FGF receptors 1c and 2c are known for their high binding affinity to FGF1, 2, 9 and 20, and we therefore examined whether these particular receptor isoforms are expressed in NZCs (Eswarakumar et al., 2005; Lavine et al., 2005; Ohmachi et al., 2003) . qPCR analysis after reaction efficiency corrections for each FGF receptor isoform demonstrates that Fgfr1c and Fgfr2c are highly enriched in mesenchyme derived
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Development 138 (23) from the nephrogenic zone compared with Fgfr1b and Fgfr2b ( Fig.  3C ; supplementary material Fig. S3B ). This suggests that CITED1 + progenitors are restricted to responding to specific FGFs owing to their predominant expression of FGF receptors 1c and 2c. Paradoxically, although Fgf1, 9 and 20 are expressed in the cap mesenchyme, the addition of exogenous FGF to cultures of these cells is required to maintain nephron progenitor cells. Predicting that expression of these FGFs might be lost during the culture period, we wished to determine whether reduced Cited1 expression correlated with reduced expression of Fgf1, 9 and 20. Analysis of NZCs cultured in medium alone for 24 hours demonstrates that transcription of Fgf1, 9 and 20 decreases significantly over the culture period, as compared with expression levels in freshly isolated NZCs (Fig. 3D ). Attenuated expression of these FGFs might contribute to the reduction of higher-order cap markers that is seen following culture in medium alone. Since Fgf1, 9 and 20 are strongly expressed in the cap mesenchyme compared with other tissues, it is possible that nephron progenitor cells contribute to the maintenance of their own renewal through FGF signaling.
FGF/EGF maintenance of early nephron progenitors requires RAS-and PI3K-mediated signaling
The EGF receptor ligands EGF and TGF maintain the nephron progenitor population in a similar manner to FGF ( Fig. 4A; Fig.  1D ). We therefore hypothesized that EGF receptor signaling might promote progenitor maintenance by increasing the expression of Fgf1, 9 and 20. Indeed, EGF receptor ligands do promote the expression of Fgf1 and Fgf9, as does FGF2 treatment (Fig. 4A,  inset) .
To functionally test the possibility that EGF receptor ligands promote the progenitor cell state indirectly by activating FGF signaling, we treated NZCs with either EGF or TGF in the presence or absence of the small molecule PD173074, a specific ATP-binding inhibitor of FGFR1, 2 and 3 (Bansal et al., 2003; Pardo et al., 2009) . As expected, treatment of NZCs with PD173074 abolished the CITED1 expression promoted by FGF2; however, EGF and TGF were still able to maintain the CITED1 population in the presence of the FGF receptor inhibitor (Fig. 4B) . Thus, endogenously produced FGFs do not appear to be responsible for the effects of EGF and TGF on CITED1 + progenitor maintenance, at least in vitro.
FGF and EGF receptors frequently utilize overlapping intracellular signal transduction mediators, in particular RAS (Schlessinger, 2004) . To test the possibility that both EGF and FGF receptors promote the progenitor cell state through RAS, we repeated the inhibition experiment using a small-molecule RAS inhibitor. In contrast to the results with the FGF inhibitor, CITED1 expression was extremely sensitive to the RAS inhibitor FPT III at one-quarter of the established IC50 dose, which significantly lowered CITED1 expression in response to FGF and EGF receptor ligands (Fig. 4B) .
FGF and EGF signaling pathways can be further separated into ERK and PI3K branches. Immunofluorescent analysis in the presence of ERK and PI3K inhibitors demonstrates that CITED1 expression is controlled by the PI3K pathway (Fig. 4B ). An interesting feature of this experiment is that ERK inhibition appears to have a slight stimulatory effect on CITED1 expression. Although this was not statistically significant, we wanted to determine whether ERK inhibition might promote Cited1 expression by inhibiting Spry1 transcription. qPCR reveals that this is not the case (supplementary material Fig. S4) .
Overall, we conclude that FGFs, EGF and TGF maintain CITED1 + progenitors through activation of a common RAS/PI3K-dependent RTK signaling program.
RTK-mediated RAS signaling is required to maintain the expression of primitive nephron progenitor markers in vivo
The NZC culture system propagates a mixture of cell types representative of the nephrogenic zone. To ascertain whether RTK signaling might be acting directly on nephron progenitors, rather than secondarily through other cells in the culture, we designed an in vivo experiment to specifically abrogate the response of CITED1 + nephron progenitor cells to RTK signaling. Sprouty (Spry) proteins inhibit RTK-mediated RAS activation, affecting both the FGF and 5103 RESEARCH ARTICLE RTK signaling in nephron progenitors Fig. 2 . FGF candidates are redundantly expressed in distinct subcompartments of the nephrogenic zone. Tissue expression mined from GUDMAP was used to generate the heatmap shown (reprinted with permission from the GUDMAP consortium). Baseline (black) is derived from the median value for each gene across all tissues within each platform-specific dataset. Red denotes expression above baseline, and blue expression below baseline. UB, ureteric bud; UT, ureteric tip; CI, cortical interstitium; RV, renal vesicle; e, embryonic day; p, postnatal day.
EGF signaling pathways (Mason et al., 2006) . The Spry1 gene is normally expressed in the collecting duct of the kidney and acts as an essential modulator of RTK signaling through the c-Ret receptor, negatively regulating ureteric bud branching (Basson et al., 2005) . To develop an in vivo system with which to study the effects of FGFR/EGFR-RAS signaling in the CITED1 + progenitor compartment, we used a Spry1 Cre-inducible mouse strain, in which expression of the mouse Spry1 cDNA is driven by a ubiquitous CMV enhancer and -actin promoter (Yang et al., 2008) .
We first tested the ability of Spry1 overexpression to block CITED1 expression in NZCs derived from embryos of Spry1 transgenic (Spry1-Tg) mice. Transduction of NZCs with Creexpressing adenovirus demonstrated that a ~3-fold increase in Spry1 transcription results in a significant reduction in CITED1 protein expression, as compared with controls treated with adenovirus containing a GFP cassette (Fig. 5A) . To obtain the necessary spatial and temporal specificity of Spry1 expression in vivo, we bred the Spry1-Tg transgene onto the Cited1-CreER T2 transgenic strain that expresses the Cre:estrogen receptor fusion protein (CreER T2 ) under the control of Cited1 regulatory elements (Fig. 5B) (Boyle et al., 2008) . Previous studies have demonstrated that recombination can be induced specifically in nephron progenitors of Cited1-CreER T2 transgenic mice by tamoxifen treatment of the dam at a variety of stages throughout kidney development. To gain insight into the degree of recombination expected following a 24-hour tamoxifen induction, Cited1-CreER T2 transgenics were bred to R26R lacZ mice, which constitutively express -galactosidase (-gal) under the control of the Rosa26 promoter after Cre excision of loxP-flanked stop sequences (Soriano, 1999) . Pregnant dams were injected with tamoxifen intraperitoneally at E16.5 and embryonic kidneys were harvested after 24 hours from R26R lacZ mice that were either positive or negative for the Cited1-CreER T2 driver. As shown by X-gal staining of frozen kidney sections from Cited1-CreER T2 ;R26R lacZ transgenics, some variability is seen within the same kidney, with recombination varying from 50% to 90% of cells in individual cap
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Development 138 (23) Fig. 5C ; supplementary material Fig. S5 ). Because -gal expression is heritable, cells contributing to nascent nephron structures, such as renal vesicles, can be detected. Within the 24-hour period following the tamoxifen pulse, many progenitors of the CITED1 + compartment had progressed to the induced mesenchymal compartment, whereas a more limited number were found in renal vesicles.
mesenchymes (
From our primary cell analyses, we predicted that FGFR/EGFR signaling through RAS would be necessary to maintain the progenitor cell state within the cap mesenchyme, and we therefore compared the expression of WT1, PAX2, SIX2 and CITED1 by immunostaining in wild-type (Spry1-Tg) and mutant (Cited1-CreER T2 ;Spry1-Tg) kidneys at E17.5. The expression of the general cap mesenchyme markers WT1 and PAX2 is very similar in wildtype and mutant kidneys, and, together with Hematoxylin and Eosin staining, demonstrates that cap mesenchyme is still present in the mutant (Fig. 6A,B; supplementary material Figs S6, S7).
However, as predicted from the in vitro overexpression of Spry1 in NZCs (Fig. 5A) , the majority of CITED1 protein expression is lost from the nephrogenic zone of mutant kidneys as compared with the wild type ( Fig. 6A-C; supplementary material Fig. S8 ). Also, a marked decrease in SIX2 protein expression was observed ( Fig.  6B,C; supplementary material Fig. S8 ). Transcriptional analysis of freshly isolated NZCs from mutant and wild-type kidneys verified decreases in early nephron progenitor markers including Cited1, Meox1, Pea3 and Six2, whereas markers of the cortical interstitium (Foxd1, Sfrp1) remained largely unchanged (Fig. 6D) . Considering that CITED1
+ progenitors represent only 50% of the mixed NZC isolate, a 1.5-fold increase in Spry1 expression may translate to a 3-fold increase specifically within the CITED1 + compartment, as was observed in Spry1-Tg NZCs infected with Cre + adenovirus ( Fig. 6D; Fig. 5A ). From this analysis we conclude that progenitors in the CITED1 + compartment require RTK-mediated RAS signaling to maintain their cellular identity in vivo. To ascertain whether RTK signaling through RAS is required for nephron progenitor maintenance at developmental stages earlier than E16.5, we repeated our transgenic experiment with tamoxifen injection at E12.5 and harvest at E13.5. Although a tendency can be seen toward reduction of CITED1 and SIX2 expression in the nephrogenic zone of Cited1-CreER T2 ;Spry1-Tg kidneys, both markers remain expressed, indicating that the effect of SPRY1 expression on nephron progenitors is less pronounced in the early kidney (supplementary material Fig. S9 ). (Fig. 7A) . In addition, those cells that could be found in Spry1-overexpressing mice were largely restricted to the cap mesenchyme and did not contribute significantly to the pretubular aggregate compartment in comparison with Cited1-CreER T2 ;R26R lacZ controls (Fig. 7A ). In agreement with this finding, transgenic Spry1 overexpression was also associated with a ~50% loss of the pretubular aggregate marker LEF1 ( Fig. 7B,C ;R26R lacZ kidneys demonstrates recombination in the cap mesenchyme 24 hours after a single tamoxifen injection of the pregnant dam. An X-gal staining negative control is shown in supplementary material Fig. S5 . IM, induced mesenchyme; RV, renal vesicle. and the overall effect on nephrogenesis must be considered very mild, raising the possibility that a 50% reduction in LEF1 might have only a marginal impact on the number of nephrons formed.
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Spry1 perturbs the developmental fate of early nephron progenitors
As we have shown in both primary cell studies and the Spry1 transgenic model that early nephron progenitor cells lose their marker identity in the absence of FGF/EGF-mediated RAS signaling, we tested the possibility that CITED1 + progenitors overexpressing Spry1 are prematurely removed from the progenitor pool. Indeed, we observed a ~5-fold increase in TUNEL labeling in mesenchyme cells surrounding ureteric bud tips, supporting the conclusion that cells overexpressing Spry1 are more susceptible to cell death (Fig. 7A,B) . This finding was confirmed in kidneys harvested 12 hours after tamoxifen injection by immunostaining for cleaved caspase 3, an earlier marker of cell death (Fig. 8C) . Because little or no morphological change other than an accumulation of pyknotic nuclei is apparent in the nephrogenic zone of mutant kidneys, we tested the hypothesis that increased proliferation of cap mesenchyme cells might compensate for the loss of cells in the mutant. Indeed, we find a ~2-fold increase in the number of cells positive for the mitosis marker pHH3 within the cap mesenchyme of mutant kidneys (Fig.  8D,E) . Furthermore, analysis of -gal-positive and -negative progenitors from Cited1-CreER
T2
;R26R lacZ ;Spry1-Tg mice reveals that those progenitors that have not undergone recombination display a very significant proliferative advantage over those that have recombined (Fig. 8F,G) . Although we do find significant increases in both cell death and proliferation within the cap progenitor compartment of Cited1-CreER T2 ;Spry1-Tg kidneys, these effects might not entirely explain the profound dilution of transgenic cap mesenchyme cells shown in the lineage-tracing experiments. Rather, we hypothesize that transgenic cap cells are diluted out due to a combined effect of cell cycle slowing/exit, cell death and compensatory expansion of wild-type progenitors.
Fgf1 and Fgf9 are expressed by the cap mesenchyme and maintain primitive nephron progenitor marker expression in vitro ( Fig. 2; Fig.  3A,B) . Furthermore, we demonstrated in vitro that transcription of Fgf1 and Fgf9 was induced by FGF/EGF ligands that promote early progenitor markers in a RAS-dependent manner (Fig. 4A) . A transcriptional survey of NZCs derived from Cited1-CreER;Spry1-Tg transgenic mice revealed that Fgf1 and Fgf9 expression was decreased by ~70% and ~40%, respectively, suggesting that these ligands are indeed regulated by RTK-mediated RAS signaling in vivo (Fig. 9A) . A global reduction in the expression of FGFs that normally act in an autocrine manner to maintain early progenitor markers might help to explain why remaining -gal-negative progenitors in the cap of Cited1-CreER T2 ;R26R lacZ ;Spry1-Tg mice display decreased levels of early progenitor markers ( Fig. 7A; Fig. 6) .
Recently, canonical Wnt signaling has been identified as a requirement for maintenance of the Cited1-expressing progenitor population of the E11.5 kidney (Karner et al., 2011) . To establish whether FGF could be maintaining the CITED1 + population by modulating Wnt signaling, we treated our NZC cultures with the canonical Wnt activator BIO. Wnt activation does not affect the capacity of FGF to maintain CITED1 + progenitors ( Fig. 9B ; supplementary material Fig. S2 ). However, a subset of the genes that have been identified as Wnt targets in the early kidney are activated by FGF in the presence or absence of the Wnt inhibitor IWR1, showing that FGF activates these targets in a Wnt-independent manner (Fig. 9C) . Furthermore, the expression of these genes is reduced in NZCs from CreER T2 ;R26R lacZ ;Spry1-Tg kidneys (Fig.  9D ). These data suggest that the maintenance of nephron progenitors might have a differential requirement for Wnt and FGF signaling during early (E11.5) versus later (E17.5) nephrogenesis.
DISCUSSION
High-resolution gene expression studies have revealed that nephron progenitor cells are located in a series of compartments within the nephrogenic zone (Mugford et al., 2009) . The signals that regulate the distribution of nephron progenitor cells in distinct compartments are poorly understood, and their elucidation will provide essential insights into normal nephrogenesis and
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Development 138 (23) developmental kidney malformations. The earliest compartment, which expresses CITED1, is predicted to possess the greatest capacity for self-renewal and differentiation (Boyle et al., 2008) . Although CITED1 is an important molecular marker for the earliest nephron progenitor cell compartment, the transcription factor itself is not essential for kidney development (Boyle et al., 2007) . However, redundancy with CITED2 remains a possibility, and the early lethality of the Cited2 null mouse has precluded this analysis at the later developmental time points that we focused on in our study. We found that RTK activation by FGF and EGF receptor ligands maintains the early CITED1 + nephron progenitor phenotype in a RAS-dependent manner. A number of FGF and EGF receptor ligands are expressed within the nephrogenic zone, suggesting extensive redundancy in vivo. Blockade of RTK signaling by transgenic Spry1 overexpression resulted in the loss of early progenitor cell markers and in increased apoptosis in the cap mesenchyme. Moreover, lineage tracing demonstrated that remaining labeled progenitors overexpressing Spry1 were unable to contribute to the pretubular aggregate and renal vesicle compartments. We conclude that redundant FGF/EGF-mediated RAS signaling regulates the maintenance and developmental potential of the early nephron progenitor cell population.
Several reports suggest that EGF receptor ligands might regulate the survival of nephron progenitor cells. Neutralizing antibody treatments of kidney organ culture show that TGF is required for kidney development in vitro (Rogers et al., 1992) . Furthermore, in combination with FGF2 or conditioned medium from ureteric bud cells, TGF promotes the survival of isolated E13 rat metanephric mesenchyme, indicating that it has a survival-promoting effect on early nephron progenitor cells (Barasch, 1999; Karavanova et al., 1996) . However, unlike FGF2, TGF treatment is not sufficient to rescue isolated metanephric mesenchyme from death in culture, indicating that its role is limited to augmenting survival (Karavanova et al., 1996) . The EGFR ligand amphiregulin is under the transcriptional control of the transcription factor WT1, which is expressed in nephron progenitor cells. Amphiregulin protein is abundant in the nephrogenic zone, and it promotes the growth of cultured kidneys suggesting that it might act as a proliferative factor for nephron progenitor cells . One caveat to the interpretation of organ culture treatment experiments is the fact that many studies have been conducted using rat kidneys, which respond differently to growth factor treatment than mouse kidneys. Compound genetic inactivation of EGF, TGF and amphiregulin in the mouse does not perturb kidney development, 5109 RESEARCH ARTICLE RTK signaling in nephron progenitors ;Spry1-Tg mice display increased levels of (C) the early apoptosis marker cleaved caspase 3 (CASP3) and (D) the mitosis marker pHH3 in the cap mesenchyme 12 hours after tamoxifen injection. One hundred and eighty-five cap mesenchymes were counted and averaged from each of four mice per group. (E) Representative images co-stained for pHH3 (yellow) and SIX2 (green demonstrating that they are not required for the maintenance of nephron progenitors in vivo (Luetteke et al., 1999) , perhaps owing to their functional redundancy with FGFs.
Genetic and organ culture experiments indicate roles for FGF signaling in nephron progenitor cell maintenance. FGF2 supports proliferation and inhibits apoptosis of isolated metanephric mesenchymes (Barasch et al., 1997; Dudley et al., 1999; Perantoni et al., 1995) , promoting expression of the anti-apoptosis gene Wt1 (Perantoni et al., 1995) . Similar to the findings of our study, this effect cannot be reproduced with FGF7 but can be reproduced with FGF1 (Barasch et al., 1997) . Compound conditional inactivation of FGF receptors 1 and 2 in the mesenchyme of the developing kidney results in arrest of nephrogenesis at ~E11.5, demonstrating an essential role for FGF signaling in the development of the metanephric mesenchyme (Poladia et al., 2006) . Several FGF ligands are expressed within the developing kidney, and genetic inactivation studies have revealed phenotypes for Fgf7, Fgf8 and Fgf10 mutants. Inactivation of Fgf7 and Fgf10, known ligands for FGF receptor b isoforms, result in defects in collecting duct branching (Michos et al., 2010; Ohuchi et al., 2000; Qiao et al., 1999) . In this study, we found evidence that early nephron progenitors residing within the cap mesenchyme express a class of FGFs (Fgf1, 9 and 20) that normally bind FGF receptor c isoforms and are capable of promoting renewal of early CITED1 + progenitors. In accordance, our gene expression analyses indicate that NZCs display predominant expression of Fgfr1c and Fgfr2c. Recent genetic studies in mice further support this notion and demonstrate that, in the absence of Fgfr1, there is a specific requirement for the c isoform of Fgfr2 in the development of the metanephric mesenchyme, including the maintenance of the Six2 and Pax2 progenitor compartments. Taken together, these data suggest that early nephron progenitors might rely, in part, on FGF receptor/ligand signaling that acts in an autocrine manner for their maintenance (Sims-Lucas et al., 2011) .
Genetic inactivation studies have shown a requirement for Fgf8 in the survival of CITED1 + nephron progenitors within the nephrogenic zone (Grieshammer et al., 2005; Perantoni et al., 2005) . However, in contrast to FGF1, 2, 9 and 20, we find that FGF8 has a very weak effect on the CITED1 + progenitor phenotype. This is surprising considering that all of these FGFs are predicted to signal through the c isoforms of the FGF receptors. Although a technical explanation for this effect cannot be entirely ruled out, we have titrated independent lots of FGF8 with defined ED 50 values over an extensive concentration range, finding a high concordance of results. Our finding that nephron progenitor cells are insensitive to FGF8 might be explained by the fact that the decoy receptor Fgfrl1 is expressed specifically in the cells of the cap mesenchyme (GUDMAP). In direct binding studies, FGFRL1 has high affinity for FGF8, but shows little or no binding with FGF1, 9 and 20, and intermediate binding with FGF2 (Steinberg et al., 2010) . Thus, FGFRL1 might modulate the sensitivity of CITED1 + cells to stimulation by FGFs, suppressing the response to FGF8. Although the Fgfrl1 null mouse displays a strong developmental phenotype in the kidney, inferences regarding interactions with FGF8 cannot be made from the mutant analysis because Fgf8 is not expressed due to the blockage of nephron differentiation (Gerber et al., 2009 ).
Wnt signaling is required for maintenance of the nephron progenitor cell compartment in the E11.5 kidney (Karner et al., 2011) , and we therefore speculated that Wnt signaling might lie downstream of FGF/EGF in the cap mesenchyme. Our experiments using both an activator and an inhibitor of canonical Wnt signaling
Development 138 (23) demonstrate that this is not the case. However, a subset of gene targets activated by canonical Wnt signaling are also activated by FGF. This partial overlap in gene activation might indicate that FGF/EGF lies downstream of Wnt, as has previously been described in development of the forebrain (Paek et al., 2011) . Alternatively, it might indicate that Wnt and FGF/EGF are two independent circuits that activate a common program required for nephron progenitor maintenance. The finding that Sprouty antagonism of RTK signaling impacts CITED1 and SIX2 progenitor maintenance more severely at E17.5 than at E12.5 supports the notion that these two pathways are required at different times during nephrogenesis.
Our results might have important implications regarding the pathophysiology of neoplasms such as in Wilms' tumor, which resemble renal progenitors in a state of arrested differentiation. Failure in FGF/EGF feedback control by genes such as Sprouty might contribute to the undifferentiated metanephric blastema found in Wilms' tumor, where the advanced stage of the disease is known to be correlated with persistent expression of early blastemal markers such as Cited1 and Meox1 (Williams et al., 2004; Li et al., 2005; Lovvorn et al., 2007a; Lovvorn et al., 2007b) . The FGF/EGF signaling pathway components that are disrupted by Spry1, or genes that alter Spry1 activity, might represent novel therapeutic targets to combat Wilms' tumor and other cancers that arise from parent stem cells that normally display a requirement for FGF signaling during self-renewal.
